Business Context and Reporting Period
Company: Supernus Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 2, 2016
Reporting Period: Second quarter ended June 30, 2016
This filing serves as a notification that the Company issued a press release regarding its financial results for the second quarter of 2016. The detailed financial data is contained in Exhibit 99.1 (Press Release), which is incorporated by reference but not explicitly detailed within the text of this 8-K form.
Key Financial Metrics
The text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release (Exhibit 99.1) and the upcoming conference call.
Material Changes
No specific material changes or comparative financial data versus the prior period are disclosed in the body of this filing. The filing indicates that the Company will present these results during a conference call.
Guidance, Outlook, and Risks
- Conference Call: The Company scheduled a conference call for August 3, 2016, at 9:00 a.m. Eastern Time to present financial results. A live webcast was available at www.supernus.com.
- Forward-Looking Statements: The filing contains forward-looking statements regarding plans, strategies, and intentions. These are subject to risks and uncertainties, including those detailed in Item 1A ("Risk Factors") of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015.
- Legal Status: The information in Item 2.02 is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, limiting liability under that section.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release Dated August 2, 2016) for specific Q2 2016 revenue, net loss, and cash position figures.
- Access the archived webcast or listen to the conference call recording from August 3, 2016, for management commentary on operational performance.
- Consult the Form 10-K filed on March 9, 2016, for a comprehensive list of risk factors affecting forward-looking statements.
- Verify the Company's cash runway and burn rate, as specific liquidity numbers are not present in this summary document.